- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 30.35M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 30.74M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 30.76M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1.82M |
| Capex | Q1 2026 · Mar 31, 2025 | $2.1M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $24.86M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $837K |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $77.61M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $78.43M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $517.07M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $559.27M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $520.37M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $505.25M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $329M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $290.8M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.5B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.69B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.02B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.2B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.19 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.99 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.19 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.99 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $24.91M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $23.86M |
| Net Income | Q1 2026 · Mar 31, 2026 | $36.48M |
| Net Income | Q1 2026 · Mar 31, 2025 | $30.47M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $50.82M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $42.44M |
| Revenue | Q1 2026 · Mar 31, 2026 | $212.66M |
| Revenue | Q1 2026 · Mar 31, 2025 | $211.52M |